This inventor holds 1 USPTO granted patent. Top assignee: Nisshin Flour Milling Co., Ltd.. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Ryotaro Kojima: Innovator in Pharmaceutical Chemistry
Introduction
Ryotaro Kojima is a notable inventor based in Saitama-ken, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications.
Latest Patents
Kojima holds 1 patent for his work on imide derivatives aimed at inhibiting the production of interleukin-1 beta. His patent describes imide compounds that possess a propioloyl group or pharmaceutically acceptable salts. These compounds exhibit potent activities to inhibit the production of interleukin-1 beta and tumor necrosis factor alpha. They are particularly useful as prophylactic or therapeutic agents for various diseases, including chronic rheumatism, sepsis, ulcerative colitis, and Crohn's disease.
Career Highlights
Kojima is currently employed at Nisshin Flour Milling Co., Ltd., where he continues to innovate in the field of pharmaceutical research. His work has the potential to impact the treatment of diseases that involve interleukin-1 beta and tumor necrosis factor alpha.
Collaborations
Kojima collaborates with esteemed colleagues such as Shinji Yokoyama and Noriyoshi Sueda, contributing to a dynamic research environment that fosters innovation.
Conclusion
Ryotaro Kojima's contributions to pharmaceutical chemistry highlight the importance of innovative research in developing therapeutic agents. His work continues to pave the way for advancements in treating various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile